Drug Database
Back to search

France· FR:64961378

ONDANSETRON ARROW 8 mg, comprimé orodispersible

A ondansetron product containing ondansétron, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A04AA01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedONDANSETRON ARROW 8 mg, comprimé orod…ATCA04AA01REGISTER NO.FR:64961378PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ondansétronAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ondansetron is registered in 19 of 19 countries.

Countries holding a registration under ATC A04AA01 (ondansetron), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose
Search ondansetron products by name

Ondansetron · ATC A04AA01

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ondansetron costs, country by country.

Normalised to the WHO defined daily dose (16 mg), the median price runs from $0.23 in United States to $18.43 in Switzerland — a ×79 gap.

  • France: $5.36 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Ondansetron · price per daily dose (16 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$18.43
  • IT Italy$14.68
  • FR France$5.36
  • US United States$0.23 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ONDANSÉTRON
Manufacturer
ARROW GENERIQUES
Country
France (FR)
ATC code
A04AA01
ATC class
Ondansetron
Defined daily dose
16 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400937815123
    plaquette(s) polyamide aluminium PVC-Aluminium PETP : copolymère de polytéréphta.d'éthlè.glycol et de diéthylè.glycol de 2 comprimé(s)
    EUR 4.71
  • cip13
    3400937815291
    plaquette(s) polyamide aluminium PVC-Aluminium PETP : copolymère de polytéréphta.d'éthlè.glycol et de diéthylè.glycol de 4 comprimé(s)
    EUR 9.32

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

841 interactions on record for ondansetron.

Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ondansetron against other medicinesHow interaction checks work

Ondansetron · interactions on record

841 records

  • 139 severe
  • 240 moderate
  • 6 minor
  • 402 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • FenfluramineA08AA02severe

54 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ondansetron in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ondansetron products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ondansan, Ondansan I.V.
  • Belgium · Ondansetron Ab, Ondansetron Accord Healthcare
  • Bulgaria · Zofran, Зондарон
  • Cyprus · Ondansetron Accord, Ondansetron Noridem
  • Czechia · Novetron, Ondansetron Accord
  • Germany · Cellondan, Ondansetron 1 A Pharma
  • Denmark · Ondansetron "kalceks", Ondansetron "stada"
  • Estonia · Ondansetron Accord, Ondansetron Basi
  • Spain · Ondansetrón Accord, Ondansetron Aristo
  • Finland · Ondansetron Accord, Ondansetron Accordpharma
  • United Kingdom (Northern Ireland) · Ametron Melt, Emistem
  • Greece · Cruzafen, Odasen
  • Croatia · Ondansetron Kalceks, Ondanzetron Kabi
  • Hungary · Emetron, Ondansetron Kabi
  • Ireland · Emizof, Ondansetron Accord Healthcare Ireland
  • Iceland · Cinveron, Ondansetron Bluefish
  • Italy · Emistop, Ondansetron Accord
  • Lithuania · Ondansetron Accord, Ondansetron Basi
  • Luxembourg · Avessaron, Ondansetron B. Braun
  • Latvia · Emetron, Ondansetron Accord
  • Malta · Emytron, Ondansetron Accord Healthcare Ireland
  • Netherlands · Ondansetron Accord, Ondansetron Aspire
  • Norway · Ondansetron Accord, Ondansetron Accordpharma
  • Poland · Atossa, Ondansetron Accord
  • Portugal · Danevon, Emytron
  • Romania · Ondansetron Aurobindo, Ondansetron Kabi
  • Sweden · Ondansetron Accord, Ondansetron Accordpharma
  • Slovenia · Ondansetron Accord, Ondansetron Baxter
  • Slovakia · Ondansetron Accord, Ondansetron B. Braun

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ae40d00f-458a-4d76-8a7e-c22569659ad1
GET /v1/drugs/ae40d00f-458a-4d76-8a7e-c22569659ad1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64961378",
  "date_amm": "2006-12-27",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ONDANSÉTRON",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé orodispersible",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about ondansetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console